Benefits of MXLTM
The problem
In Alzheimer's disease, brain cells undergo continuous injury and are eventually lost.
Some brain cells were lost Yesterday...
More will be lost Today...
Even more will be lost Tomorrow...
No one drug or treatment can protect all of these brain cells...
The solution
MXL is not a drug, but a combination of 6 vitamins and nutritional factors that work together to:
- Revive brain cells injured yesterday
- Stop the damage in those injured today
- Protect the rest from injury tomorrow
Help your loved one reconnect with
- their world
- themselves
- with you
MXL is not designed to replace any prescribed medication or treatment, and is available without prescription. This product is not intended to diagnose, cure or treat any disease. These statements have not been evaluated by the FDA.
Following are the Results from the 1-year Clinical Trial of a Group with Early-Stage Alzheimer's disease. The clinical trial results were published in The The American Journal of Alzheimer's Disease & other Dementias.
"Activities of Daily Living"
This test measures a person’s ability to carry out daily tasks that are important for independence, such as:
- using the telephone & other appliances
- conversing with others
- preparing/helping with meals
- personal care (bathing, dressing, grooming)
When a loved one can no longer carry out these tasks, it can force a working family to consider the need for a nursing home.
The Caregivers of the group with early-stage Alzheimer's disease reported that their loved ones maintained performance in these daily tasks for 12 months so far while taking MXL
MXL can help them take care of themselves and can help them stay home with you.
"Neuropsychiatric Inventory"
This test measures how severely a person’s behavior and well-being is affected in Alzheimer's disease
Persons with Alzheimer's disease often
- become anxious, depressed & irritable
- lose their appetite
- have trouble walking
- have trouble sleeping
The Caregivers of the group with early-stage Alzheimer's disease reported that their loved ones showed less and less of these symptoms over the past 12 months while taking MXL
MXL can provide a better quality of life for persons with early-stage Alzheimer's disease.
"Dementia Rating Scale"
This test measures the ability of a person with Alzheimer's disease to follow directions, focus on a task
Persons with Alzheimer's disease often
- become confused easily
- forget where they left something
- have trouble following directions
- have trouble completing simple tasks
We asked the group with early-stage Alzheimer's disease to complete this test before and every 3 months while taking MXL. They showed an average continued improvement over 12 months.
MXL can help persons with early-stage Alzheimer's disease think more clearly.
Don’t wait until it’s too late. Take care of your brain cells before you lose them!
Make MXL a part of caring for your brain, along with good nutrition and mental exercise!
"MXLTM speeds up response-time in adults without Alzheimer's disease"
Normal adults took MXL or placebo for 3 months and completed the standard "Trail-Making" test. We then also gave the placebo group MXL and continued for another 3 months.
This standard cognitive test consists of two parts:
- In the first part (Trails A), participants connect a series of circles numbered from 1-25.
- The second part (Trails B) is similar, but now participants must connect circles that alternate in numbers and letters (1, A, 2, B, 3, C, 4, D, etc.).
Trails A measures ability to follow directions.
Trails B adds decision-making to the tasks of Trails A.
Subtracting the time required to complete Trails A from the time required to complete Trials B measures any change in decision-making alone.
- Total of 90 participants (45 received MXL; 45 placebo) from 5 trials
- Participants receiving MXL improved by an average of 10-20%.
- Participants receiving the placebo did not improve at first, but after receiving MXL, they also improved by 10-20%.
- Statistically-significant improvement: p<0.03@ 3 months, 0.01@ 6 months